@misc{indiciaed384d896468a,
  title = {SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness},
  author = {Corbett, K. S. and Edwards, D. and Leist, S. R. and Abiona, O. M. and Boyoglu-Barnum, S. and Gillespie, R. A. and Himansu, S. and Schafer, A. and Ziwawo, C. T. and DiPiazza, A. T. and Dinnon, K. H. and Elbashir, S. M. and Shaw, C. A. and Woods, A. and Fritch, E. J. and Martinez, D. R. and Bock, K. W. and Minai, M. and Nagata, B. M. and Hutchinson, G. B. and Bahl, K. and Garcia-Dominguez, D. and Ma, L. and Renzi, I. and Kong, W.-P. and Schmidt, S. D. and Wang, L. and Zhang, Y. and Stevens, L. J. and Phung, E. and Chang, L. A. and Loomis, R. J. and Altaras, N. E. and Narayanan, E. and Metkar, M. and Presnyak, V. and Liu, C. and Louder, M. K. and Shi, W. and Leung, K. and Yang, E. S. and West, A. and Gully, K. L. and Wang,},
  year = {2020},
  doi = {10.1101/2020.06.11.145920},
  url = {https://www.biorxiv.org/content/10.1101/2020.06.11.145920v1},
  note = {Source identifier: 10.1101/2020.06.11.145920}
}